Ireland· IE-PA-EU/1/99/123/005-007
Renagel 400 mg Film-coated tablet
A drugs for treatment of hyperkalemia and hyperphosphatemia product containing sevelamer, registered in Ireland by Sanofi Winthrop Industrie. The same ATC class is registered in 2 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Sevelamer is registered in 2 of 19 countries.
Countries holding a registration under ATC V03AE (drugs for treatment of hyperkalemia and hyperphosphatemia), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Sevelamer · ATC V03AE
2 / 19 countries
- Belgiumprice
- Ireland
The record
At a glance
HPRA (Ireland)- Active substance
- Sevelamer
- Manufacturer
- Sanofi Winthrop Industrie
- Country
- Ireland (IE)
- ATC code
- V03AE
- ATC class
- Drugs for treatment of hyperkalemia and hyperphosphatemia
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/99/123/005-007
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sevelamer in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainHIDROCLORURO DE SEVELAMERO WAYMADE 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAWaymade B.V.
- IcelandRenagelSanofi Winthrop Industrie
- NetherlandsRenagel 400 mg filmomhulde tablettenSanofi Winthrop Industrie
- PolandRenagelSanofi Winthrop Industrie
- United KingdomRenagel 403mg capsulesGenzyme Therapeutics Ltd
- FranceCHLORHYDRATE DE SEVELAMER WAYMADE 800 mg, comprimé pelliculéWAYMADE (PAYS-BAS)
- ItalyRENAGEL*180 cpr rivestite 800 mg flaconeSANOFI WINTHROP INDUSTRIE
- SwitzerlandRenagel, comprimés pelliculésSanofi-Aventis (Suisse) SA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d6da0883-3732-41d3-a9c7-189ebf241c8e GET /v1/drugs/d6da0883-3732-41d3-a9c7-189ebf241c8e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"V03AE"
],
"strength": null,
"pa_number": "EU/1/99/123/005-007",
"substances": [
"Sevelamer"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "23/04/2001",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about sevelamer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.